p53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation

Transplantation

Volumn 69, Issue 5, 2000, Pages 994-996

  Marshall, Sara E ^a   Bordea, Cristina ^a   Wojnarowska, Fenella ^a   Morris, Peter J ^a   Welsh, Ken I ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROTEIN P53;

ARTICLE; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SKIN CANCER; TUMOR SUPPRESSOR GENE; WART VIRUS;

EID: 0034654006     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00056     Document Type: Article

References (10)

1. Hardie IR. Skin cancer in transplant recipients. Transplant Rev 1995; 9: 1.
2. Boyle J, MacKie RM, Briggs JD, Junor BJR, Aitchison TC. Cancer, warts, and sunshine in renal transplant patients: a case-control study. Lancet 1984; 1: 702.
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49.
4. Scheffner M, Werness BA, Huibregste JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129.
5. Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998; 393: 229.
6. Bunce M, Barnardo MCNM, Procter J, et al. High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibrium in 604 unrelated random UK Caucasoids, and a comparison with serology. Tissue Antigens 1996; 48: 680.
7. Bunce M, O'Neill C, Barnardo MCNM, et al. "Phototyping": comprehensive DNA typing for HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, and -DQB alleles by 144 PCR reactions utilising sequence specific primers (SSP). Tissue Antigens 1995; 46: 355.
8. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 1998; 2: 871.
9. Klaes R, Ridder R, Schaefer U, Benner A, von Knebel Doeberitz M. No evidence of p53 allel-specific predisposition in human papillomavirus-associated cervical cancer. J Mol Med 1999; 77: 299.
10. Hayes VM, Hofstra RMW, Buys CHCM, Hollema H, van der Zee AGJ. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet 1998; 2: 1756.